V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20164080 | 20063129 | 1.67 | 74.1 | Neo-adjuvant (N) | 2017-01-03 | 2017-01-05 | ECX | 02 | N | ECX | 100654187 |
| 20164084 | 20063130 | 1.72 | 65.4 | Adjuvant (A) | 2017-05-10 | 2017-05-10 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100994943 |
| 20164085 | 20063131 | 1.6 | 75 | Neo-adjuvant (N) | 2018-01-07 | 2018-01-13 | ECX | 2 | N | ECX | 101454798 |
| 20164090 | 20063132 | 1.71 | 82.3 | Adjuvant (A) | 2017-08-13 | 2017-08-18 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100636760 |
| 20164094 | 20063133 | 1.81 | 86 | Neo-adjuvant (N) | 2016-08-31 | 2016-09-06 | ECX | 02 | N | ECX | 101271736 |
| 20164097 | 20063134 | 1.62 | 58 | Palliative (P) | 2017-07-01 | 2017-07-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100347800 |
| 20164103 | 20063135 | 1.71 | 64.2 | Adjuvant (A) | 2018-12-29 | 2018-12-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101297397 |
| 20164106 | 20063136 | null | 77 | Palliative (P) | 2018-11-22 | 2018-11-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100904367 |
| 20164116 | 20063137 | 1.58 | 55.9 | Curative (C) | 2016-12-18 | 2017-01-01 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101715622 |
| 20164118 | 20063138 | 1.65 | 63.4 | Palliative (P) | 2016-01-28 | 2016-02-08 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100680787 |
| 20164123 | 20063139 | 1.53 | 62.3 | Adjuvant (A) | 2018-04-28 | 2018-05-24 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100167921 |
| 20164130 | 20063140 | 1.7 | 76.8 | Palliative (P) | 2018-07-12 | 2018-07-29 | ECX | 02 | N | ECX | 100696929 |
| 20164132 | 20063141 | 1.8 | 78.5 | Neo-adjuvant (N) | 2018-12-11 | 2018-12-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101373051 |
| 20164134 | 20063142 | 1.8 | 66.6 | Palliative (P) | 2018-10-09 | 2018-10-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101773169 |
| 20164136 | 20063143 | 1.68 | 63 | Neo-adjuvant (N) | null | 2016-02-14 | ECX | N | N | ECX | 101414099 |
| 20164147 | 20063144 | 1.77 | 101.3 | Adjuvant (A) | 2018-08-05 | 2018-08-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100518481 |
| 20164149 | 20063145 | 1.78 | 67.2 | Palliative (P) | 2016-07-20 | 2016-08-06 | ECX | N | N | ECX | 101202918 |
| 20164153 | 20063146 | 1.72 | 60 | null | 2018-04-13 | 2018-04-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101185398 |
| 20164156 | 20063147 | 1.75 | 77.1 | Neo-adjuvant (N) | 2017-05-18 | 2017-05-27 | ECX | N | N | ECX | 100343988 |
| 20164158 | 20063148 | 1.63 | 86 | null | 2018-01-20 | 2018-02-04 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100360947 |
| 20164160 | 20063149 | 1.78 | 76 | Palliative (P) | 2018-12-17 | 2018-12-29 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100163758 |
| 20164167 | 20063150 | 1.52 | 97.4 | Palliative (P) | 2020-10-16 | 2020-10-16 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100495543 |
| 20164169 | 20063151 | 1.7 | 67.8 | Adjuvant (A) | 2016-05-20 | 2016-05-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101111833 |
| 20164176 | 20063152 | 1.57 | 72.4 | Palliative (P) | 2018-02-17 | 2018-02-18 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100172334 |
| 20164177 | 20063153 | 1.77 | 98.2 | Palliative (P) | 2019-02-22 | 2019-03-09 | ECX | N | null | ECX | 100522649 |
| 20164178 | 20063154 | 1.53 | 67 | Palliative (P) | 2018-05-22 | 2018-05-22 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100640854 |
| 20164180 | 20063155 | 1.74 | 97 | Neo-adjuvant (N) | null | 2018-03-27 | ECX | null | N | ECX | 100724040 |
| 20164182 | 20063156 | 1.66 | 89 | Adjuvant (A) | 2018-07-08 | 2018-07-27 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100851572 |
| 20164183 | 20063157 | 1.85 | 67.3 | Neo-adjuvant (N) | 2016-07-04 | 2016-07-11 | ECX | N | N | ECX | 100261056 |
| 20164186 | 20063158 | 1.72 | 65.4 | Neo-adjuvant (N) | 2018-08-07 | 2018-08-15 | ECX | N | N | ECX | 101675664 |
| 20164195 | 20063159 | 1.77 | 109.1 | Adjuvant (A) | 2018-10-16 | 2018-10-25 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100771680 |
| 20164199 | 20063160 | 1.78 | 73 | Neo-adjuvant (N) | 2016-11-19 | 2016-12-10 | ECX | N | N | ECX | 101100298 |
| 20164200 | 20063161 | 1.7 | 82 | Palliative (P) | 2017-11-13 | 2017-11-13 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 100878357 |
| 20164202 | 20063162 | 1.61 | 67.15 | Curative (C) | 2017-01-04 | 2017-01-12 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101226308 |
| 20164205 | 20063163 | 1.59 | 107.1 | Neo-adjuvant (N) | 2017-03-04 | 2017-03-18 | ECX | 02 | N | ECX | 100164796 |
| 20164207 | 20063164 | 1.7 | 58.9 | Adjuvant (A) | 2019-03-25 | 2019-04-10 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100569669 |
| 20164208 | 20063165 | 1.68 | 104 | Neo-adjuvant (N) | 2018-06-13 | 2018-06-13 | ECX | 02 | N | ECX | 101024529 |
| 20164214 | 20063166 | 1.59 | 70 | Adjuvant (A) | 2016-03-31 | 2016-03-31 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101838023 |
| 20164217 | 20063167 | 1.79 | 95.6 | Neo-adjuvant (N) | 2016-10-27 | 2016-10-28 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101265274 |
| 20164220 | 20063168 | 1.81 | 73.6 | Palliative (P) | 2016-06-19 | 2016-06-20 | ECX | 02 | null | ECX | 100799414 |
| 20164233 | 20063169 | 1.72 | 74 | Adjuvant (A) | 2018-10-01 | 2018-10-07 | ECX | N | N | ECX | 100220264 |
| 20164241 | 20063170 | 1.8 | 85.4 | null | 2017-06-11 | 2017-07-02 | ECX | N | N | ECX | 101642331 |
| 20164244 | 20063171 | 1.72 | 59 | Neo-adjuvant (N) | 2015-09-13 | 2015-09-17 | ECX | N | N | ECX | 101229289 |
| 20164245 | 20063172 | 1.58 | 74.05 | Neo-adjuvant (N) | 2018-08-05 | 2018-09-03 | ECX | 02 | null | ECX | 100113583 |
| 20164247 | 20063173 | 1.72 | 92.4 | Palliative (P) | 2019-06-17 | 2019-06-17 | ECX | N | N | ECX | 101450230 |
| 20164250 | 20063174 | 1.7 | 76.2 | Palliative (P) | 2018-07-14 | 2018-08-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100606086 |
| 20164263 | 20063175 | 1.67 | 67.7 | Neo-adjuvant (N) | 2019-10-27 | 2019-11-21 | ECX | 02 | N | ECX | 101528076 |
| 20164268 | 20063176 | 1.59 | 67.2 | Adjuvant (A) | 2016-08-30 | 2016-09-22 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100942500 |
| 20164285 | 20063177 | 1.82 | 43 | Palliative (P) | 2019-12-04 | 2019-12-04 | Gemcitabine + Capecitabine | 2 | null | CAPECITABINE + GEMCITABINE | 101304651 |
| 20164289 | 20063178 | 1.7 | 78 | Neo-adjuvant (N) | 2016-08-14 | 2016-09-07 | ECX | 02 | N | ECX | 100951498 |